A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

INTRODUCTION: To evaluate the efficacy and safety of sirukumab in giant cell arteritis (GCA). METHODS: In this multicentre, randomised, double-blind, placebo-controlled, two-part phase 3 trial (NCT02531633; Part A [52-week double-blind treatment]; Part B [104-week follow-up]), patients with GCA were...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Wolfgang A., Dasgupta, Bhaskar, Luqmani, Raashid, Unizony, Sebastian H., Blockmans, Daniel, Lai, Zhihong, Kurrasch, Regina H., Lazic, Ivana, Brown, Kurt, Rao, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695797/
https://www.ncbi.nlm.nih.gov/pubmed/32844378
http://dx.doi.org/10.1007/s40744-020-00227-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695797/
https://www.ncbi.nlm.nih.gov/pubmed/32844378
http://dx.doi.org/10.1007/s40744-020-00227-2

Ejemplares similares